Recommendations for the Development and Implementation of Generative Artificial Intelligence Tools in Pediatric Clinical Care: Policy Statement

The integration of generative artificial intelligence (GenAI) into pediatric health care offers exciting opportunities alongside critical challenges. GenAI tools, like large language models (LLMs), show promise in several health care applications, including but not limited to clinical decision support, documentation, and medical education across a wide range of pediatric subspecialties. However, real-world validation remains limited, and concerns persist around accuracy, bias, reliability, sustainability, and du…

By the Truvace deskOctober 4, 20261 min read1 sourcePeer-reviewedTRV-2026-1273· cite & verify

In brief

On October 3 2026, Pediatrics published a policy statement on generative AI tools including large language models in pediatric health care. It describes potential uses in decision support, documentation, and education, while noting limited real-world validation and persistent concerns about accuracy, bias, and reliability.

The statement matters because children and adolescents may face distinct risks from models trained largely on adult data, including poorer performance and widening disparities across race, ethnicity, gender, language, ability, and socioeconomic status. It remains uncertain how to ensure diverse pediatric data, effective oversight, and adaptive governance while preserving trust and privacy.

Main points

Policy statement addresses generative AI and large language models in pediatric clinical care across subspecialties.
Studies cited indicate LLMs often underperform in pediatrics compared with adult specialties, with limited real-world validation.
Recommendations call for diverse pediatric datasets, bias mitigation, privacy safeguards, validation protocols, human oversight, and postmarket surveillance.

The problem

In pediatric care, LLMs often underperform relative to adult specialties and risk exacerbating health disparities due to biased or nonrepresentative training data.

The rundown

The Pediatrics policy statement published Oct 3 2026 reviews GenAI and LLMs for clinical decision support, documentation, and medical education in pediatrics, noting promise but limited real-world validation.

It flags accuracy, bias, reliability, sustainability, and durability concerns, cites underperformance in pediatrics versus adult specialties, and recommends diverse pediatric datasets, privacy safeguards, rigorous validation, human oversight, pediatric-specific evaluation, postmarket surveillance, and disclosure of GenAI involvement.